Complement C4d-specific antibodies for the diagnosis of lung cancer.

Oncotarget · 2018 · PMC5814217 · PMID 29464077

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In support of the superiority of the specific determination of C4d, differences in plasma levels of C4d-containing fragments in patients with lung cancer and individuals without the disease did not reach statistical significance in any of the VUMC cohorts ( Supplementary Figures 1D, 1E and 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.